Literature DB >> 16169168

Ganoderma lucidum mycelia enhance innate immunity by activating NF-kappaB.

Mei-Chun Kuo1, Ching-Yi Weng, Choi-Lan Ha, Ming-Jiuan Wu.   

Abstract

Ganoderma lucidum is a popular medicinal mushroom in China and Japan for its immunomodulatory and antitumor effects. The goal of this research is to investigate the effect of dried mycelia of Ganoderma lucidum produced by submerged cultivation on the enhancement of innate immune response. We found that Ganoderma lucidum mycelia (0.2-1.6 mg/ml) stimulated TNF-alpha and IL-6 production after 8h treatment in human whole blood. IFN-gamma release from human whole blood was also enhanced after 3 day-culture with Ganoderma lucidum mycelia (0.2-1.0mg/ml). However, Ganoderma lucidum mycelia did not potentiate nitric oxide production in RAW264.7 cells. To better understand the possible immuno-enhancement mechanisms involved, we focused on nuclear factor (NF)-kappaB activation. Electrophoretic mobility shift assay revealed that the Ganoderma lucidum mycelia (1.6 mg/ml) activated kappaB DNA binding activity in RAW264.7 cells. These results provide supporting evidences for the immunomodulatory effect of Ganoderma lucidum mycelia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16169168     DOI: 10.1016/j.jep.2005.08.010

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  13 in total

1.  Immunostimulating activity by polysaccharides isolated from fruiting body of Inonotus obliquus.

Authors:  Dong Pil Won; Jong Seok Lee; Duck Soo Kwon; Keun Eok Lee; Won Cheol Shin; Eock Kee Hong
Journal:  Mol Cells       Date:  2010-12-22       Impact factor: 5.034

2.  Antitumor effects and mechanisms of Ganoderma extracts and spores oil.

Authors:  Chun Chen; Peng Li; Ye Li; Guan Yao; Jian-Hua Xu
Journal:  Oncol Lett       Date:  2016-08-29       Impact factor: 2.967

3.  Application of serum pharmacology in evaluating the antitumor effect of Fuzheng Yiliu Decoction from Chinese medicine.

Authors:  Xu-zheng Chen; Zhi-yun Cao; Lian-ming Liao; Zhi-zhen Liu; Jian Du
Journal:  Chin J Integr Med       Date:  2013-11-16       Impact factor: 1.978

4.  Ethnomycological Investigation in Serbia: Astonishing Realm of Mycomedicines and Mycofood.

Authors:  Jelena Živković; Marija Ivanov; Dejan Stojković; Jasmina Glamočlija
Journal:  J Fungi (Basel)       Date:  2021-04-29

5.  Regulatory T Cells, a Potent Immunoregulatory Target for CAM Researchers: Modulating Allergic and Infectious Disease Pathology (II).

Authors:  Aristo Vojdani; Jonathan Erde
Journal:  Evid Based Complement Alternat Med       Date:  2006-04-19       Impact factor: 2.629

6.  Bioconversion of ginsenosides in the american ginseng ( xī yáng shēn) extraction residue by fermentation with lingzhi ( líng zhī, ganoderma lucidum).

Authors:  Bo Yang Hsu; Chia Hui Chen; Ting Jang Lu; Lucy Sun Hwang
Journal:  J Tradit Complement Med       Date:  2013-04

7.  Establishment and evaluation of biotechnological platform for screening health food with antiinflammation ability.

Authors:  Wang-Ju Hsieh; Shih-Ting Chiou; Min-Hsiung Pan; Shu-Chen Hsieh
Journal:  J Tradit Complement Med       Date:  2012-01

8.  Optimizing a culture medium for biomass and phenolic compounds production using Ganoderma lucidum.

Authors:  Carlos Andrés Zárate-Chaves; María Camila Romero-Rodríguez; Fabián Camilo Niño-Arias; Jorge Robles-Camargo; Melva Linares-Linares; María Ximena Rodríguez-Bocanegra; Ivonne Gutiérrez-Rojas
Journal:  Braz J Microbiol       Date:  2013-05-17       Impact factor: 2.476

9.  Polyphenol extract from Phellinus igniarius protects against acrolein toxicity in vitro and provides protection in a mouse stroke model.

Authors:  Papawee Suabjakyong; Ryotaro Saiki; Leo J L D Van Griensven; Kyohei Higashi; Kazuhiro Nishimura; Kazuei Igarashi; Toshihiko Toida
Journal:  PLoS One       Date:  2015-03-26       Impact factor: 3.240

Review 10.  Ganoderma: A Cancer Immunotherapy Review.

Authors:  Yu Cao; Xiaowei Xu; Shujing Liu; Linfang Huang; Jian Gu
Journal:  Front Pharmacol       Date:  2018-10-25       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.